WO2003054219A3 - Nucleic acid-associated proteins - Google Patents

Nucleic acid-associated proteins Download PDF

Info

Publication number
WO2003054219A3
WO2003054219A3 PCT/US2002/041115 US0241115W WO03054219A3 WO 2003054219 A3 WO2003054219 A3 WO 2003054219A3 US 0241115 W US0241115 W US 0241115W WO 03054219 A3 WO03054219 A3 WO 03054219A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
naap
associated proteins
polynucleotides
agonists
Prior art date
Application number
PCT/US2002/041115
Other languages
French (fr)
Other versions
WO2003054219A2 (en
Inventor
Yalda Azimzai
Original Assignee
Incyte Corp
Yalda Azimzai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Yalda Azimzai filed Critical Incyte Corp
Priority to EP02792511A priority Critical patent/EP1506304A2/en
Priority to AU2002358273A priority patent/AU2002358273A1/en
Publication of WO2003054219A2 publication Critical patent/WO2003054219A2/en
Publication of WO2003054219A3 publication Critical patent/WO2003054219A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.
PCT/US2002/041115 2001-12-19 2002-12-18 Nucleic acid-associated proteins WO2003054219A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02792511A EP1506304A2 (en) 2001-12-19 2002-12-18 Nucleic acid-associated proteins
AU2002358273A AU2002358273A1 (en) 2001-12-19 2002-12-18 Nucleic acid-associated proteins

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US34300401P 2001-12-19 2001-12-19
US60/343,004 2001-12-19
US34763302P 2002-01-11 2002-01-11
US60/347,633 2002-01-11
US35174902P 2002-01-25 2002-01-25
US60/351,749 2002-01-25
US35949802P 2002-02-22 2002-02-22
US60/359,498 2002-02-22

Publications (2)

Publication Number Publication Date
WO2003054219A2 WO2003054219A2 (en) 2003-07-03
WO2003054219A3 true WO2003054219A3 (en) 2004-11-18

Family

ID=27502664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/041115 WO2003054219A2 (en) 2001-12-19 2002-12-18 Nucleic acid-associated proteins

Country Status (3)

Country Link
EP (1) EP1506304A2 (en)
AU (1) AU2002358273A1 (en)
WO (1) WO2003054219A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394330B2 (en) 2012-03-21 2016-07-19 Alios Biopharma, Inc. Solid forms of a thiophosphoramidate nucleotide prodrug

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208267B2 (en) 2000-11-22 2007-04-24 Diadexus, Inc. Compositions and methods relating to breast specific genes and proteins
EP2307548A4 (en) * 2008-07-08 2012-06-27 Otago Innovation Ltd Methods and compositions for promoting bone growth
CN103209987B (en) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 Substituted nucleotide analog
AU2012358804B2 (en) 2011-12-22 2018-04-19 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
EP2827876A4 (en) 2012-03-22 2015-10-28 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog
AU2019249422A1 (en) 2018-04-02 2020-10-15 Grail, Llc Methylation markers and targeted methylation probe panels
CA3111887A1 (en) 2018-09-27 2020-04-02 Grail, Inc. Methylation markers and targeted methylation probe panel
CA3127894A1 (en) * 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 16 September 1997 (1997-09-16), TANABE SEIYAKU CO., XP002904015, accession no. EMBL Database accession no. AAT91873 *
DATABASE GENBANK [online] 16 September 1997 (1997-09-16), TANABE SEIYAKU CO., XP002904016, accession no. EMBL Database accession no. AAW30749 *
DATABASE GENBANK [online] 1998, IMAI ET AL: "Cloning of gene, YT521, for a novel RNA splicingrelated protein induced by hypoxia/reoxygenation", XP002904017, accession no. EMBL Database accession no. Q9QY02 *
DATABASE GENBANK [online] 1999, HARTMANN ET AL: "The interaction and colocalization of sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the src family kinase p59(fyn)", XP002904012, accession no. NCBI Database accession no. AF144731 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394330B2 (en) 2012-03-21 2016-07-19 Alios Biopharma, Inc. Solid forms of a thiophosphoramidate nucleotide prodrug

Also Published As

Publication number Publication date
WO2003054219A2 (en) 2003-07-03
EP1506304A2 (en) 2005-02-16
AU2002358273A1 (en) 2003-07-09
AU2002358273A8 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2003052075A3 (en) Enzymes
WO2002063005A3 (en) Lipid-associated molecules
WO2003094848A3 (en) Nucleic acid-associated proteins
WO2003029437A3 (en) Secreted proteins
WO2002072794A3 (en) Immunoglobulin superfamily proteins
WO2003042357A3 (en) Enzymes
WO2003004615A3 (en) Secreted proteins
WO2003054219A3 (en) Nucleic acid-associated proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2002026950A3 (en) Transferases
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2003060064A3 (en) Intracellular signaling molecules
WO2002101009A3 (en) Structural and cytoskeleton-associated proteins
WO2003038052A3 (en) Nucleic acid-associated proteins
WO2003010329A3 (en) Nucleic acid-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2001083524A3 (en) Rna metabolism proteins
WO2003063769A3 (en) Vesicle-associated proteins
WO2003031939A3 (en) Protein modification and maintenance molecules
WO2002099115A3 (en) Nucleic acid-associated proteins
WO2003016549A3 (en) Nucleic-acid associated proteins
WO2003006618A3 (en) Nucleic acid-associated proteins
WO2003016506A3 (en) Secreted proteins
WO2003000864A3 (en) Nucleic acid-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2002792511

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002792511

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002792511

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP